Ex-SAC Trader Cites Cohen As Trial Approaches

Dec 9 2013 | 12:46pm ET

Lawyers for former SAC Capital Advisors portfolio manager Mathew Martoma on Friday asked the judge presiding over his insider-trading case to exclude a great volume of potential evidence against him—while also allowing them to quote from firm founder Steven Cohen's deposition before the Securities and Exchange Commission.

Cohen is not likely to testify at Martoma's trial next month, citing his Constitutional right against self-incrimination. But Martoma's lawyers would like his testimony from last year to speak for him—and to show that Martoma had nothing to do with the trades that led to his indictment.

In a pre-trial motion, Martoma's lawyers cited Cohen's statements that he elected to sell the firm's stake in pharmaceutical company Wyeth LLC not because Martoma suggested he do so—but because former SAC trader Wayne Holman did. Holman, who ran the defunct Ridgeback Capital Management, had a $20 million consulting deal, and Cohen said that the week SAC sold Wyeth, Holman "was telling me he was selling his Wyeth."

Cohen said he judged Holman to be "one of the great healthcare investors I have ever met" whose "recommendations are very important to me." He also called him a "good friend."

"I don't recall much other than that he was telling me he is selling his—he is selling some Wyeth," Cohen said. "I know he was nervous about the world" in 2008, "the macro picture, but he didn't give me any specifics."

Martoma's lawyers also wish to use Cohen's words to keep out testimony about SAC's trading strategy for Wyeth and another drug company, Elan Corp.

"Generally, what I remember was selling Wyeth and then deciding to hedge out my exposure in Wyeth by shorting Elan," Cohen said. "It was sort of imperfect. I was estimating the ratio that I would need to sell one against the other, but that's what I did."

Prosecutors allege that Martoma urged Cohen to sell the stocks after a doctor overseeing a drug trial run by the two companies warned him that things were not going well. That doctor, Sidney Gilman, is set to testify against Martoma.

Cohen did mention Martoma during his testimony, but noted that Martoma's recommendation was only part of his decision to buy both stocks prior to the poor test results.

"They are both coming at it from different stocks," Cohen said. "Martoma liked both names and Wayne liked Wyeth."

In addition to seeking the admission of Cohen's deposition, Martoma's legal team also asked U.S. District Judge Paul Gardephe to block prosecutors from discussing SAC's sale of Wyeth shares and how the hedge fund shorted Elan and Wyeth.

Martoma's trial is scheduled to begin on Jan. 6.


In Depth

Q&A: Brevan Howard’s Charlotte Valeur Talks Strategy

Sep 18 2014 | 11:18am ET

Charlotte Valeur chairs the board of Brevan Howard Credit Catalysts, an LSE listed...

Lifestyle

Hedgies Rock Out For Children's Charity

Sep 15 2014 | 8:40am ET

It's that time of year again—when hedgies trade in their spreadsheets for guitars...

Guest Contributor

Volkered: How Financial Sector Reforms are Creating Opportunities for Hedge Funds

Sep 16 2014 | 11:28am ET

New regulations have dramatically curtailed proprietary trading activity in investment...

 

Editor's Note

    Get A Sneak Peak Of The Alpha Pages

    Aug 25 2014 | 11:21am ET

    As many of you know, FINalternatives was recently acquired by the owners of Futures magazine, a firm called The Alpha Pages LLC. Today marks the soft-launch of a new sister site for both publications. As its name suggests, The Alpha Pages will cover all types of alternative investments, going far beyond the more well-known ones such as hedge funds and private equity. Read more…

 

Futures Magazine

September 2014 Cover

The London Whale: Rogue risk management

Credit default swaps brought down the London Whale and cost JPMorgan $6.2 billion. Here is how it happened.

The Alpha Pages

TAP July/August 2014 Cover

The Alpha Pages Interview: Senator Rand Paul

Senator Paul sat down in the debut series of the Alpha Pages Interview to discuss the broken tax code, regulation surrounding Bitcoin, and his plans for the 2016 Presidential election.